Myriad Genetics, Inc. · NASDAQ:MYGN
Myriad Genetics, Inc. shareholders
As of Sep 30, 2026, 170 institutions reported holding Myriad Genetics, Inc., 90.6% of its shares. Largest: BlackRock, Vanguard and Millennium. New holders, exits, insiders and big stakes, each with its filing.
| Holder | Shares | % of Myriad Genetics, Inc. | Change | Filed |
|---|---|---|---|---|
| BlackRock | 15.9M | 16.6% | +5.03M | Nov 13, 2026 |
| Vanguard | 7.66M | 8.0% | −320K | Nov 16, 2026 |
| Millennium | 7.23M | 7.5% | +609K | Nov 16, 2026 |
| State Street | 4.8M | 5.0% | −186K | Nov 12, 2026 |
| D. E. Shaw & Co., Inc. | 4.69M | 4.9% | +105K | Nov 16, 2026 |
| Acadian Asset Management LLC | 3.46M | 3.6% | +331K | Nov 9, 2026 |
| Point72 Asset Management, L.P. | 3.23M | 3.4% | +2.99M | Nov 16, 2026 |
| Mackenzie | 2.5M | 2.6% | +964K | Nov 2, 2026 |
| Citadel | 2.15M | 2.2% | +619K | Nov 16, 2026 |
| Marshall Wace, LLP | 2.07M | 2.2% | +850K | Nov 13, 2026 |